VIAFIBER HSA Trademark

Trademark Overview

On Friday, July 8, 2022, a trademark application was filed for VIAFIBER HSA with the United States Patent and Trademark Office. The USPTO has given the VIAFIBER HSA trademark a serial number of 97494204. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Monday, April 21, 2025. This trademark is owned by Globus Medical, Inc.. The VIAFIBER HSA trademark is filed in the Pharmaceutical Products category with the following description:

Implant material for use in spine surgery composed of human allograft tissue
viafiber hsa

General Information

Serial Number97494204
Word MarkVIAFIBER HSA
Filing DateFriday, July 8, 2022
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateMonday, April 21, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesImplant material for use in spine surgery composed of human allograft tissue
NOT AVAILABLE"HSA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 24, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlobus Medical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAudubon, PA 19403

Trademark Events

Event DateEvent Description
Wednesday, July 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 24, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, August 24, 2022TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, December 14, 2022ASSIGNED TO EXAMINER
Monday, December 19, 2022NON-FINAL ACTION WRITTEN
Monday, December 19, 2022NON-FINAL ACTION E-MAILED
Monday, December 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 27, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, March 27, 2023EXAMINERS AMENDMENT E-MAILED
Monday, March 27, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 27, 2023EXAMINER'S AMENDMENT ENTERED
Monday, March 27, 2023SUSPENSION LETTER WRITTEN
Monday, March 27, 2023LETTER OF SUSPENSION E-MAILED
Monday, March 27, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 25, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, March 25, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, September 22, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, April 18, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, April 21, 2025REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, October 22, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

Related Keywords

viafiber human allograft tissue composed surgery material spine implant